Mankind Pharma Ltd - 543904 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Company will host Investor Conference Call on Thursday, May 16, 2024 at 12:00 Noon (IST) for Q4FY24 and FY24. Mankind Pharma Ltd - 543904 - Board Meeting Intimation for Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Mankind Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2024 ,inter alia, to consider and approve the standalone and consolidated audited financial results of the Company for the quarter and financial year ended on March 31, 2024 and to evaluate various options or proposals for raising funds through any of the permissible modes, subject to the receipt of necessary approvals. Mankind Pharma Ltd - 543904 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the financial year ended March 31, 2024 Mankind Pharma Ltd - 543904 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Mankind Pharma Ltd - 543904 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (Listing Regulations)
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Credit Rating
Intimation of Credit Rating assigned by a Credit Rating Agency. Mankind Pharma Ltd - 543904 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyMankind Pharma Ltd 2CIN NO.L74899DL1991PLC044843 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY None 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Pradeep Chugh Designation: Company Secretary and Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: Ashutosh Dhawan Designation: Chief Financial Officer EmailId: [email protected] Date: 19/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. Mankind Pharma Ltd - 543904 - Certificate Under Regulation 40(9) & (10) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Certificate under Regulation 40(9) & (10) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Mankind Pharma Ltd - 543904 - Update On Scheme Of Arrangement For Amalgamation Of Shree Jee Laboratory Private Limited, JPR Labs Private Limited And Jaspack Industries Private Limited With Mankind Pharma Limited
Update on Scheme of Arrangement for Amalgamation of Shree Jee Laboratory Private Limited, JPR Labs Private Limited and Jaspack Industries Private Limited with Mankind Pharma Limited